ASTS
AST SpaceMobile, Inc.
ASTS trails on the overall score without a compensating advantage in the available component scores.
DAKT
Daktronics, Inc.
DAKT has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DAKT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
DAKT's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
DAKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $19.50 | — |
| Cheap | 17x | $16.85 | -14% |
| Current | 20x | $19.50 | — |
| Fair | 38x | $37.44 | +92% |
| Expensive | 193x | $191 | +879% |
Historical ranges are pointers, not guarantees.
DAKT's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
DAKT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for DAKT, with profitability improving. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
DAKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.49 | +51% |
| Q3 2026 | $0.99 | +$1.00 |
| Q2 2026 | $0.92 | +$1.37 |
| Q1 2026 | $0.54 | +$0.74 |
| Q4 2025 | $0.12 | -52% |
| Q3 2025 | -$0.01 | -113% |
| Q2 2025 | -$0.45 | -174% |
| Q1 2025 | -$0.20 | -119% |
| Q4 2024 | $0.25 | -76% |
DAKT has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over DAKT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
DAKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $234.6M | +7.1% |
| Q2 2026 | $208.6M | +21% |
| Q1 2026 | $181.9M | +22% |
| Q4 2025 | $229.3M | +10% |
| Q3 2025 | $219M | -3.1% |
| Q2 2025 | $172.6M | -20% |
| Q1 2025 | $149.5M | -12% |
| Q4 2024 | $208.3M | +4.5% |
DAKT's revenue has grown year over year for four quarters in a row: $235M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | 0 points |
| Q2 2026 | 6.8% | +7.8 points |
| Q1 2026 | 1.1% | +3.5 points |
| Q4 2025 | 9.4% | +1.8 points |
| Q3 2025 | 11% | +0.6 points |
| Q2 2025 | -1% | -10 points |
| Q1 2025 | -2.4% | -7.2 points |
| Q4 2024 | 7.6% | -2.2 points |
DAKT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
DAKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $27.3M | +25% |
| Q2 2026 | -$9.6M | -153% |
| Q1 2026 | $8.1M | +3.4% |
| Q4 2025 | $14M | -63% |
| Q3 2025 | $21.8M | +51% |
| Q2 2025 | $18M | +196% |
| Q1 2025 | $7.8M | +54% |
| Q4 2024 | $38M | +86% |
DAKT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
DAKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -481K shares |
| 1 year | -1.7% | -835K shares |
| 3 years | +5.9% | +2.7M shares |
| 5 years | +7.7% | +3.5M shares |
| Available history | +8% | +3.6M shares |
DAKT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4M |
| Q2 2026 | $2.8M |
| Q1 2026 | $10.6M |
| Q4 2025 | $1.6M |
| Q3 2025 | $10.7M |
| Q2 2025 | $20.5M |
| Q2 2024 | — |
| Q2 2023 | — |
DAKT spent $19M buying back its own shares over the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DAKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
DAKT has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
DAKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 46.5 | Neutral |
DAKT's weekly RSI is 51 (neutral) and its Stochastic is 46 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
DAKT PE vs Technology Sector
| Metric | DAKT | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 28x | 29% below |
| PE % | 20 | 35 | 15 pts below |
DAKT is trading at 20x earnings, a 29% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
DAKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 4.3% above |
| 20 week MA | $19.1 | 1.9% above |
| 50 week MA | $20.2 | 3.5% below |
| 100 week MA | $18.3 | 6.8% above |
| 200 week MA | $13.8 | 41% above |
DAKT has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
DAKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.01 | $4.80 | -20% |
| 2021 | $4.80 | $5.08 | +5.8% |
| 2022 | $5.08 | $2.97 | -42% |
| 2023 | $2.97 | $8.48 | +186% |
| 2024 | $8.48 | $17.0 | +100% |
| 2025 | $17.0 | $18.6 | +9.4% |
| 2026 YTD | $18.6 | $19.5 | +5.1% |
DAKT has the edge over ASTS on returns for 2026, with the stronger performance.